🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
LEG
$LEGN
🔒 US EquitiesLegend Biotech Corporation-ADR
AVG HISTORICAL GAP
+1.04%
MAX GAP RECORD
+7.03%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $LEGN
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$LEGN
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 11, 2026 Earnings Release 2026-11-11 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 11, 2026 Earnings Release 2026-08-11 (BEFORE OPEN) |
+5.40%
|
| Mar 10, 2026 Earnings Release 2026-03-10 (BEFORE OPEN) |
+0.34%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN) |
+1.84%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (BEFORE OPEN) |
+1.22%
|
| May 13, 2025 Earnings Release 2025-05-13 (BEFORE OPEN) |
-4.35%
|
| Mar 11, 2025 Earnings Release 2025-03-11 (BEFORE OPEN) |
-0.09%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN) |
-0.32%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.9%
Bullish Gaps (6)
Bearish Gaps (1)
Neutral / Flat (7)
📖 Intelligence Summary
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗